Context Therapeutics Inc.(CNTX)

Biotechnology · Philadelphia, PA

$0.34+0.00 (+1.16%)

Delayed quote: Oct 6, 2026, 10:58 AM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T15:02:02.925Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:02:02.925Z.

Quote observation: 2026-10-06T14:58:14.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 31,275,673
TTM operating cash flow · period ending 2026-06-30: -33,970,930

FMP input reference: c88c4f39e0f2b8ce509c05ad310ef4a925915372bb385716b1b31bbca6f45484

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNTX Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

CNTX Competitors' Price/OCF Ratio

CNTX

Context Therapeutics Inc.

Current

Market Cap

$31.28M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs CNTX

Market Cap

$31.26M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs CNTX

Market Cap

$31.03M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDMD

Baird Medical Investment Holdings Limited

vs CNTX

Market Cap

$31.36M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSYS

Nortech Systems Incorporated

vs CNTX

Market Cap

$31.77M

Price/OCF Ratio

10.36

TTM Avg

11.37

3Y Avg

193.26

5Y Avg

145.59

MDXH

MDxHealth S.A.

vs CNTX

Market Cap

$31.10M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRVO

CervoMed Inc.

vs CNTX

Market Cap

$30.18M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs CNTX

Market Cap

$29.95M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EUDA

EUDA Health Holdings Limited

vs CNTX

Market Cap

$32.72M

Price/OCF Ratio

N/A

TTM Avg

503.18

3Y Avg

503.18

5Y Avg

503.18

ALGS

Aligos Therapeutics, Inc.

vs CNTX

Market Cap

$33.04M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Context Therapeutics Inc. (CNTX)	$31.28M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$31.26M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.03M	N/A	N/A	N/A	N/A
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.36M	N/A	N/A	N/A	N/A
Nortech Systems Incorporated (NSYS)vs ›	$31.77M	10.36	11.37	193.26	145.59
MDxHealth S.A. (MDXH)vs ›	$31.10M	N/A	N/A	N/A	N/A
CervoMed Inc. (CRVO)vs ›	$30.18M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.95M	N/A	N/A	N/A	N/A
EUDA Health Holdings Limited (EUDA)vs ›	$32.72M	N/A	503.18	503.18	503.18
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.04M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

CNTX Price/OCF Ratio Metrics

CNTX Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics